A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of gut cancer recurrence after tumour surgery.
Over two million people worldwide are diagnosed with colorectal cancer every year, with up to 40 per cent of these patients facing the risk of tumour cells spreading from the gut to other parts of the body, making treatment more difficult.
